Filing metadata

Accession number
0001415889-24-028001
Form type
Form 4
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
Dec 02, 2024
Reporting period
Nov 27, 2024
Description
Insider transaction

Explore SEC Filings Hub